Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Revance Therapeutics, Inc. (RVNC) > Segments

Product

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenues  54.445.827.125.524.425.519.418.4
            Revenue growth  113.4%87.6%39.3%38.2%85.5%133.1%435.6%6064.9%
EBIT  -19.3-12.7-32.1-25.0-25.0-27.0-36.3-35.4
            EBIT margin  -35.5%-27.8%-118.7%-98.0%-102.2%-105.9%-186.9%-192.0%
   
Revenue Mix  93.6%92.8%93.2%89.8%96.6%98.1%98.4%98.0%

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy